MARK1 anticorps (AA 6-40)
Aperçu rapide pour MARK1 anticorps (AA 6-40) (ABIN3031687)
Antigène
Voir toutes MARK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 6-40
-
Fonction
- MARK1 Antibody
-
Purification
- Purified
-
Immunogène
- A portion of amino acids 6-40 from the human protein was used as the immunogen for this MARK1 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the MARK1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the MARK1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
-
Autre désignation
- MARK1
-
Sujet
- MARK is a family of kinases that is known for its involvement in establishing cell polarity and in phosphorylating tau protein during Alzheimer neurodegeneration. Expression of MARK causes the phosphorylation of MAPs at their KXGS motifs, thereby detaching MAPs from the microtubules and thus facilitating the transport of particles. This occurs without impairing the intrinsic activity of motors because the velocity during active movement remains unchanged. In primary retinal ganglion cells, transfection with tau leads to the inhibition of axonal transport of mitochondria, APP vesicles, and other cell components which leads to starvation of axons and vulnerability against stress. This transport inhibition can be rescued by phosphorylating tau with MARK
-
UniProt
- Q9P0L2
-
Pathways
- SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
Antigène
-